AQR Capital Management - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,333,250
-60.7%
28,990
-50.9%
0.00%
-57.1%
Q2 2023$3,392,799
-18.4%
59,036
-46.8%
0.01%
-22.2%
Q1 2023$4,158,263
+31.8%
110,887
-1.5%
0.01%
+28.6%
Q4 2022$3,155,136
+18.5%
112,603
+18.8%
0.01%
+16.7%
Q3 2022$2,663,000
+116.9%
94,753
+168.5%
0.01%
+100.0%
Q2 2022$1,228,000
+153.2%
35,290
+161.4%
0.00%
+200.0%
Q1 2022$485,000
+97.2%
13,499
+27.7%
0.00%
Q4 2021$246,000
-32.8%
10,575
-45.1%
0.00%
-100.0%
Q3 2021$366,000
-8.7%
19,277
-3.0%
0.00%0.0%
Q2 2021$401,000
-10.7%
19,868
-19.0%
0.00%0.0%
Q1 2021$449,000
-39.1%
24,521
-33.1%
0.00%0.0%
Q4 2020$737,000
-25.1%
36,646
-30.2%
0.00%
-50.0%
Q3 2020$984,000
-42.3%
52,475
-30.9%
0.00%
-33.3%
Q2 2020$1,706,000
+29.4%
75,973
-14.5%
0.00%
+50.0%
Q1 2020$1,318,000
+77.2%
88,846
+130.4%
0.00%
+100.0%
Q4 2019$744,000
-6.5%
38,568
-3.9%
0.00%0.0%
Q3 2019$796,000
+103.6%
40,135
+116.9%
0.00%
Q2 2019$391,000
-11.5%
18,503
-14.4%
0.00%
Q1 2019$442,000
+0.5%
21,611
-2.2%
0.00%
-100.0%
Q4 2018$440,000
-7.2%
22,103
-10.2%
0.00%
Q3 2018$474,000
+58.0%
24,626
+25.2%
0.00%
Q2 2018$300,000
-21.9%
19,663
-4.1%
0.00%
Q1 2018$384,000
-2.5%
20,5020.0%0.00%
Q4 2017$394,000
-9.6%
20,502
-16.0%
0.00%
-100.0%
Q3 2017$436,000
-63.0%
24,415
-63.0%
0.00%
-50.0%
Q2 2017$1,177,000
-18.5%
65,910
-33.9%
0.00%0.0%
Q1 2017$1,445,000
-15.4%
99,641
+7.5%
0.00%0.0%
Q4 2016$1,708,000
-15.8%
92,729
-13.3%
0.00%
-33.3%
Q3 2016$2,029,000
+217.0%
106,982
+169.4%
0.00%
+200.0%
Q2 2016$640,000
+144.3%
39,712
+81.7%
0.00%
Q1 2016$262,000
-32.5%
21,859
-19.8%
0.00%
-100.0%
Q4 2015$388,000
+37.1%
27,250
+12.7%
0.00%0.0%
Q3 2015$283,00024,1700.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 154,415$5,543,0002.96%
Nantahala Capital Management 1,000,000$35,900,0001.59%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 251,659$9,035,0001.00%
EAM Investors, LLC 124,697$4,477,0000.83%
Jackson Creek Investment Advisors LLC 49,814$1,788,0000.65%
SHAKER INVESTMENTS LLC/OH 33,794$1,213,0000.62%
EAM Global Investors LLC 91,702$3,292,0000.61%
Hillsdale Investment Management Inc. 234,338$8,412,0000.54%
GLOBEFLEX CAPITAL L P 72,300$2,596,0000.53%
Capital Impact Advisors, LLC 17,760$638,0000.46%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders